Top of this page
Skip navigation, go straight to the content
Welcome to UCB IR download center!
You should find all relevant IR-related documents: presentations, annual reports, bond prospectus, code of conduct, etc.
Haven't found what you are looking for? Do not hesitate to contact us: investor-relations@ucb.com
Agreement to acquire
Ra Pharma
On 10 October 2019, UCB announced its intention to acquire Ra Pharma based in Cambridge, MA (U.S.).
This deal was subject to anti-trust clearance. It was completed early April 2020.
Upcoming report
| Date | Event details |
|---|---|
| 27 July 2020 | 2020 half-year results 07.00 Press release 14.00 Conference call /webcast |
UCB IR App
As of 2019, UCB stopped quarterly reporting. We will provide an updated IR presentation on a regular basis.
2019 annual integrated report
2018 major documents
| 3 months | 6 months | 9 months | 12 months | |
|---|---|---|---|---|
Press release |
|
|
|
|
Presentation |  | | | |
Management report | N.A. |
| N.A. |
|
Excel data | N.A. |  | N.A. | |
2018 full year results
Click replay to listen to the conference call hosted on 28 February 2019.
2018 annual integrated report
2017 annual report
Complementary to the annual report, UCB published a sustainability report. This report is also available in English, French and Dutch.
Corporate governance documents
Corporate governance charter
Dealing code
Code of conduct
UCB annual report library
2016 annual report
2016 sustainability report
2013 annual report
2014 annual report
2015 annual report
2010 annual report
2011 annual report
2012 annual report
2009 annual report
2009 CSR report
In 2009, UCB started non-financial reporting.
From 2010 to 2015, it was part of the annual report.
2006 annual report
2007 annual report
2008 annual report
2003 annual report
2004 annual report
2005 annual report
2000 annual report
2001 annual report
2002 annual report
